MARKET

OPORF

OPORF

Hvivo
OTCPK
0.350
NaN%
Closed 09:30 09/10 EDT
OPEN
--
PREV CLOSE
0.350
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.350
52 WEEK LOW
0.350
MARKET CAP
240.94M
P/E (TTM)
-29.9145
1D
5D
1M
3M
1Y
5Y
1D
hVIVO Sets Date for Interim Results and Schedules Analyst and Investor Events
TipRanks · 6d ago
hVIVO expands into dermatology and women’s health with acquisition of CRS Berlin
TipRanks · 08/27 06:07
hVIVO Orderbook Doubles as Second-Half-Weighted Revenue Drives Growth Outlook
TipRanks · 07/23 06:11
hVIVO appoints Grant Thornton as new auditor after tender
TipRanks · 07/13 06:10
hVIVO wins Decoy Therapeutics consultancy mandate for next-generation respiratory antivirals
TipRanks · 06/01 11:09
hVIVO grants performance-linked share options to senior leadership under 2024 LTIP
TipRanks · 05/29 06:19
hVIVO Showcases Integrated Early-Stage Drug Development Platform at Capital Markets Day
TipRanks · 05/20 06:13
hVIVO Shareholders Back All Resolutions at Annual General Meeting
TipRanks · 05/13 12:41
More
About OPORF
hVIVO plc is a United Kingdom-based purpose-built, full-service international clinical development partner and engaged in human challenge trials serving biopharma companies. The Company has an end-to-end platform designed to bring important medicines to patients faster: spanning preclinical strategy, first in human studies, Phase II patient trials and specialist laboratory services, delivered through a participant database, wholly owned sites and laboratories across the UK and Germany. The Company offers integrated service lines which include consulting, clinical trials, human challenge trials, and laboratories. Its consulting provides preclinical and clinical strategy, encompassing non-clinical, clinical, CMC, pharmacokinetics, data management, biostatistics, and regulatory support to guide trial design, execution, and interpretation. The Company is also focused on Phase I/II clinical studies, particularly in dermatology and women's health.

Webull offers hVIVO PLC stock information, including OTCPK: OPORF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPORF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPORF stock methods without spending real money on the virtual paper trading platform.